title: Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
authors.forename: Karen A
authors.initials: KA
authors.lastname: Nolan
authors.forename: Pál
authors.initials: P
authors.lastname: Czobor
authors.forename: Leslie L
authors.initials: LL
authors.lastname: Citrome
authors.forename: Menachem
authors.initials: M
authors.lastname: Krakowski
authors.forename: Herbert M
authors.initials: HM
authors.lastname: Lachman
authors.forename: James L
authors.initials: JL
authors.lastname: Kennedy
authors.forename: Xingqun
authors.initials: X
authors.lastname: Ni
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Lieberman
authors.forename: Miranda
authors.initials: M
authors.lastname: Chakos
authors.forename: Jan
authors.initials: J
authors.lastname: Volavka
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D005838:Genotype; D006801:Humans; D008995:Monoamine Oxidase / Q000235:genetics*; D011110:Polymorphism, Genetic; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*
chemical_list: D014150:Antipsychotic Agents; D008995:Monoamine Oxidase; D002394:Catechol O-Methyltransferase